Results 21 to 30 of about 500 (180)

Excess shed mesothelin disrupts pancreatic cancer cell clustering to impair peritoneal colonization. [PDF]

open access: yesFASEB J
MSLN is a PDAC cancer surface antigen that is typically membrane‐bound, but is subsequently shed through the action of cell surface proteases. PDAC cells expressing MSLN and MUC‐16 on the cell surface have enhanced homotypic cell clustering that is associated with increased peritoneal metastasis.
Ewa T   +8 more
europepmc   +2 more sources

Fly Ash/Silica Fume Coral Concrete with Modified Polypropylene Fiber for Sustainable Building Construction

open access: yesAdvances in Civil Engineering, Volume 2022, Issue 1, 2022., 2022
Coral concrete made of coral sand/aggregates has attracted significant interest in the construction of coastal or artificial island buildings by saving significant economic and environmental costs for transporting the conventional building materials from mainland.
Bo Wang   +5 more
wiley   +1 more source

Supplementary materials: Micronized purified flavonoid fraction in the treatment of hemorrhoidal disease

open access: yes, 2021
This is a peer-reviewed supplementary table for the article 'Micronized purified flavonoid fraction in the treatment of hemorrhoidal disease' published in the Journal of Comparative Effectiveness Research.Summary: Hemorrhoidal disease (HD) is common in ...
Varut Lohsiriwat (8725903)   +4 more
core   +1 more source

A Randomised Controlled Trial of Micronised Purified Flavonoid Fraction vs Placebo in Patients with Chronic Venous Disease [PDF]

open access: yes, 2002
Objective: to evaluate the efficacy of a micronised purified flavonoid fraction (MPFF) in the treatment of chronic venous disease (CVD). Design: prospective double blind, randomised, control study.
Norgren, L.   +11 more
core   +2 more sources

Comparative evaluation of effect of phlebotropic agents on vascular wall permeability in preclinical studies

open access: yesАмбулаторная хирургия, 2023
Introduction. As there is insufficient evidence to date to determine phlebotropic drug preferences, further research in this area is warranted. Aim.
A. V. Buzlama   +3 more
doaj   +1 more source

Is Nonmicronized Diosmin 600 mg as Effective as Micronized Diosmin 900 mg plus Hesperidin 100 mg on Chronic Venous Disease Symptoms? Results of a Noninferiority Study

open access: yesInternational Journal of Vascular Medicine, Volume 2020, Issue 1, 2020., 2020
Background. Phlebotonics have beneficial effects on some symptoms related to chronic venous disease (CVD) of the lower limbs. The most commonly used one is diosmin, available in a pure semisynthetic form or as a micronized purified flavonoid fraction. Patients and Methods.
Marcio Steinbruch   +12 more
wiley   +1 more source

Cardiovascular Insights for the Appropriate Management of Chronic Venous Disease: A Narrative Review of Implications for the Use of Venoactive Drugs. [PDF]

open access: yesAdv Ther, 2023
Evidence suggests that chronic venous disease (CVD) may be a cardiovascular disorder, as patients with CVD are prone to developing arterial (atherosclerosis) and venous (thromboembolism) diseases. This may be partly explained by shared risk factors. Thus,
Gianesini S   +5 more
europepmc   +2 more sources

Peran dan Efektivitas Micronized Purified Flavonoid Fraction dalam Terapi Pengobatan Hemoroid Kelas I dan II [PDF]

open access: yes, 2022
Hemoroid adalah suatu penyakit tidak menular yang terjadi di daerah anorektal. Hemoroid disebabkan oleh suatu aktivitas yang memicu pelebaran dan inflamasi pembuluh darah vena di plexus haemorrhoidalis yang terdapat di sekitar anus dan rektum.
Pasaribu, Donna Mesina Rosadini   +3 more
core  

MUFFIN-PTS trial, Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome: protocol of a randomised controlled trial

open access: yesBMJ Open, 2021
Introduction After deep vein thrombosis, up to 50% of patients develop post-thrombotic syndrome (PTS). PTS is a chronic condition that reduces quality of life (QOL).
Grégoire Le Gal   +6 more
doaj   +1 more source

Current principles of symptomatic treatment of lymphovenous insufficiency

open access: yesАмбулаторная хирургия, 2023
This article provides a review of the current literature on the current principles of symptomatic treatment of lymphovenous insufficiency. Lymphovenous insufficiency is an urgent problem of modern phlebology, the prevalence of this pathology reaches 50 ...
S. S. Dunaevskaya
doaj   +1 more source

Home - About - Disclaimer - Privacy